WW
The startup develops drugs targeting key mechanisms in the tissue microenvironment to treat immune inflammation and related diseases, including cancer and osteoarthritis. Their clinical-stage therapies aim to correct dysregulated immune responses, addressing the challenges of overactive and underactive inflammatory conditions.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops drugs targeting key mechanisms in the tissue microenvironment to treat immune inflammation and related diseases, including cancer and osteoarthritis. Their clinical-stage therapies aim to correct dysregulated immune responses, addressing the challenges of overactive and underactive inflammatory conditions.